Thanks heaps team. O.K with Q1 closing soon. My predictions on some basic modelling and salient related information are as below:
- Q1 Revenue - $8.4M
- GM% - 79%. New suppliers, new sales team, new target market is creating economies of scale, economies of learning, cost compression, and improved purchasing power
- Negative Operating Cash Flow - $2.2M
- BEP 3rd or 4th 1/4 2024
- The GPO is the game changer - only our second full quarter it has been in full effect, with 1600 hospitals and 43,000 alternative sites! Reports are the GPO is in very high demand of XPERIENCE & BlastX
- The DME is in an expansion, with a second site underway to manage the demand of the DME orders!
- Further Publications of Clinical Research in 2024 with enhance the recognition in the medical community
- New sales team in critical states to increase quality of sales and revenue. Already selling in 40 states of America and increasing
- TBH (Acne) has gone National and International in global stores. We have secured a new commercial arrangement (Royalties) with TBH as per the recent presentation by IV. We have diversified income streams that are building phenomenal CAGR..
- Direct wound care sales were up 411% yoy due to the first full year of the DME!!!
- The extended Walker family have committed to the long-term future of NXS (Largest Shareholder)
- We save lives and improve patient outcomes; and reduce re-admissions. We have a solution to the global problem of Biofilm in a growing TAM of $12.5B! The USA alone does 50M surgeries PA which will benefit from our XBIO technology; and has already done so over the last four years..
- The re-rate will be in 2024. The share price will look after itself. It will trade well over the IPO of a $1 once Cash Flow positive. As of the 1st of Jan 2024, we had $9.24 M in cash with Zero debt. For a growth company to have Zero debt - very very rare!!!!!...
- IV is a Global Leader, a Global Influencer in this market, with a Global Team who is based directly in the USA. Don't underestimate this positive change agent. It hasn't even been 9 months under the new Leadership Team.
- The Investor Enquires email is great, NXS will get back to you very quick with any concerns or ideas.
- For Long Term Investors - support the product and awareness; and grab a cigar in 2024/2025.
Cheers
Monty
- Forums
- ASX - By Stock
- NXS
- Market feedback
Market feedback, page-13
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXS (ASX) to my watchlist
|
|||||
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $70.11M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.5¢ | $6.769K | 28.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3960 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 145820 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3960 | 0.240 |
1 | 11507 | 0.230 |
1 | 29297 | 0.220 |
1 | 25000 | 0.215 |
2 | 12000 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 145820 | 2 |
0.295 | 3390 | 1 |
0.310 | 45789 | 1 |
0.330 | 180900 | 3 |
0.350 | 79920 | 3 |
Last trade - 15.26pm 15/08/2024 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online